We have used a rapid ex vivo approach by employing the Cre expressing adenovirus to delete clinically relevant tumor suppressor genes (Trp53, Pten, and Rb1) from normal urothelial cells with high efficiency, as described [22]. This evidence concerns the gene RB1 and neoplasm.